Charles D. Hyman’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$43.5M Sell
297,667
-5,365
-2% -$798K 2.42% 10
2024
Q1
$47.9M Sell
303,032
-1,502
-0.5% -$239K 2.65% 9
2023
Q4
$47.7M Sell
304,534
-4,850
-2% -$744K 2.85% 7
2023
Q3
$48.2M Sell
309,384
-1,091
-0.4% -$180K 3.13% 5
2023
Q2
$51.4M Buy
310,475
+1,825
+0.6% +$295K 3.22% 5
2023
Q1
$47.8M Buy
308,650
+1,385
+0.5% +$224K 3.19% 5
2022
Q4
$54.3M Buy
307,265
+268
+0.1% +$46.3K 3.7% 4
2022
Q3
$50.2M Buy
306,997
+223
+0.1% +$37.7K 3.86% 5
2022
Q2
$54.5M Buy
306,774
+980
+0.3% +$175K 3.96% 5
2022
Q1
$54.2M Buy
305,794
+5,015
+2% +$853K 3.42% 5
2021
Q4
$51.5M Buy
300,779
+2,703
+0.9% +$443K 3.26% 5
2021
Q3
$48.1M Buy
298,076
+3,126
+1% +$533K 3.37% 5
2021
Q2
$48.6M Sell
294,950
-2,203
-0.7% -$365K 3.4% 5
2021
Q1
$48.8M Buy
297,153
+3,143
+1% +$509K 3.58% 4
2020
Q4
$46.3M Sell
294,010
-1,797
-0.6% -$265K 3.7% 4
2020
Q3
$44M Buy
295,807
+103
+0% +$15.2K 3.89% 4
2020
Q2
$41.6M Buy
295,704
+19,195
+7% +$2.8M 4.01% 3
2020
Q1
$36.3M Sell
276,509
-403
-0.1% -$57.2K 4.55% 3
2019
Q4
$40.4M Buy
276,912
+270
+0.1% +$36.6K 3.96% 2
2019
Q3
$35.8M Sell
276,642
-3,667
-1% -$483K 3.74% 2
2019
Q2
$39M Buy
280,309
+792
+0.3% +$110K 4.07% 2
2019
Q1
$39.1M Buy
279,517
+3,235
+1% +$433K 4.02% 3
2018
Q4
$35.7M Buy
276,282
+180
+0.1% +$25.1K 4.23% 2
2018
Q3
$38.1M Buy
276,102
+2,463
+0.9% +$327K 3.96% 3
2018
Q2
$33.2M Buy
273,639
+5,812
+2% +$725K 3.73% 3
2018
Q1
$34.3M Buy
267,827
+2,793
+1% +$378K 3.96% 3
2017
Q4
$37M Sell
265,034
-463
-0.2% -$64.5K 4.25% 2
2017
Q3
$34.5M Sell
265,497
-5,170
-2% -$685K 4.29% 2
2017
Q2
$35.8M Buy
270,667
+2,704
+1% +$345K 4.57% 2
2017
Q1
$33.4M Buy
267,963
+1,749
+0.7% +$209K 4.43% 2
2016
Q4
$30.7M Buy
266,214
+4,001
+2% +$462K 4.33% 2
2016
Q3
$31M Sell
262,213
-150
-0.1% -$18.2K 4.6% 2
2016
Q2
$31.8M Buy
262,363
+2,748
+1% +$312K 4.77% 2
2016
Q1
$28.1M Buy
259,615
+7,295
+3% +$755K 4.45% 2
2015
Q4
$25.9M Buy
252,320
+589
+0.2% +$59.2K 4.28% 2
2015
Q3
$23.5M Buy
251,731
+4,617
+2% +$447K 4.11% 2
2015
Q2
$24.1M Buy
247,114
+871
+0.4% +$87.2K 3.87% 2
2015
Q1
$24.8M Sell
246,243
-1,540
-0.6% -$157K 3.97% 2
2014
Q4
$25.9M Sell
247,783
-1,250
-0.5% -$132K 4.18% 2
2014
Q3
$26.5M Sell
249,033
-4,214
-2% -$437K 4.44% 2
2014
Q2
$26.5M Buy
253,247
+6,626
+3% +$670K 4.46% 2
2014
Q1
$24.2M Buy
246,621
+1,250
+0.5% +$116K 4.38% 2
2013
Q4
$22.5M Sell
245,371
-2,070
-0.8% -$191K 4.12% 2
2013
Q3
$21.5M Sell
247,441
-7,064
-3% -$634K 4.25% 2
2013
Q2
$21.9M Buy
+254,505
New +$21.6M 4.49% 2

Other funds holding JNJ

Charles D. Hyman's JNJ Position: Q2 2024 in Review

Charles D. Hyman reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2024, selling an estimated $798K and leaving 297,667 shares worth $43.5M. The position accounts for 2.42% of the portfolio, ranked #10.

Charles D. Hyman first reported a position in JNJ in Q2 2013 and has held it in 45 quarters since. The position peaked at $54.5M in Q2 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Charles D. Hyman held 297,667 shares of Johnson & Johnson worth $43.5M as of Q2 2024.
  • Charles D. Hyman sold 5,365 Johnson & Johnson shares in Q2 2024, an estimated $798K.
  • Johnson & Johnson made up 2.42% of Charles D. Hyman's portfolio in Q2 2024, its #10 holding.
  • Charles D. Hyman first reported a position in Johnson & Johnson in Q2 2013 and has held it in 45 quarters since.
  • Charles D. Hyman's Johnson & Johnson position peaked at $54.5M in Q2 2022.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.